Literature DB >> 2911125

Liver-specific expression of hepatitis B virus is determined by the combined action of the core gene promoter and the enhancer.

J Honigwachs1, O Faktor, R Dikstein, Y Shaul, O Laub.   

Abstract

The hepatitis B virus (HBV) enhancer and the core gene promoter regulate the expression of the core and polymerase genes, as well as of the 3.5-kilobase pregenomic RNA. RNA analysis and chloramphenicol acetyltransferase gene expression by plasmids carrying the HBV enhancer linked to the heterologous beta-globin or simian virus 40 early promoter demonstrated that the HBV enhancer is 3- to 20-fold preferentially expressed in human liver cells. Core gene promoter activity was mapped to a 100-base-pair fragment which was shown to be sufficient for accurate initiation of transcription. The partial tissue specificity of this promoter was demonstrated by transient transfection into various cell lines with a plasmid containing the core gene promoter linked to the heterologous simian virus 40 enhancer. When the HBV core gene promoter was examined under the control of the HBV enhancer, there was high tissue specificity in that activity could be observed only in differentiated human liver cells. These results suggest that the strict tissue specificity of HBV gene expression is determined by the combinatorial action of these two elements.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2911125      PMCID: PMC247766          DOI: 10.1128/JVI.63.2.919-924.1989

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Expression of hepatitis B viral core region in mammalian cells.

Authors:  M J Roossinck; S Jameel; S H Loukin; A Siddiqui
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

2.  Effects of the position of the simian virus 40 enhancer on expression of multiple transcription units in a single plasmid.

Authors:  T Kadesch; P Berg
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

3.  Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA.

Authors:  K Yaginuma; Y Shirakata; M Kobayashi; K Koike
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

4.  The human hepatitis B virus enhancer requires trans-acting cellular factor(s) for activity.

Authors:  S Jameel; A Siddiqui
Journal:  Mol Cell Biol       Date:  1986-02       Impact factor: 4.272

5.  Synergism between immunoglobulin enhancers and promoters.

Authors:  J V Garcia; L T Bich-Thuy; J Stafford; C Queen
Journal:  Nature       Date:  1986 Jul 24-30       Impact factor: 49.962

6.  Replication strategy of human hepatitis B virus.

Authors:  H Will; W Reiser; T Weimer; E Pfaff; M Büscher; R Sprengel; R Cattaneo; H Schaller
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

7.  Identification of a promoter element located upstream from the hepatitis B virus X gene.

Authors:  M Treinin; O Laub
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

8.  Expression and replication of the hepatitis B virus genome under foreign promoter control.

Authors:  M Junker; P Galle; H Schaller
Journal:  Nucleic Acids Res       Date:  1987-12-23       Impact factor: 16.971

9.  Discrete elements within the SV40 enhancer region display different cell-specific enhancer activities.

Authors:  B Ondek; A Shepard; W Herr
Journal:  EMBO J       Date:  1987-04       Impact factor: 11.598

10.  Transcription of woodchuck hepatitis virus in the chronically infected liver.

Authors:  T Möröy; J Etiemble; C Trépo; P Tiollais; M A Buendia
Journal:  EMBO J       Date:  1985-06       Impact factor: 11.598

View more
  46 in total

Review 1.  The underlying mechanisms for the "isolated positivity for the hepatitis B surface antigen (HBsAg)" serological profile.

Authors:  Robério Amorim de Almeida Pondé
Journal:  Med Microbiol Immunol       Date:  2010-05-11       Impact factor: 3.402

2.  Regulation of hepatitis B virus expression in progenitor and differentiated cell types: evidence for negative transcriptional control in nonpermissive cells.

Authors:  M Ott; Q Ma; B Li; S Gagandeep; L E Rogler; S Gupta
Journal:  Gene Expr       Date:  1999

3.  A new enhancer element, ENII, identified in the X gene of hepatitis B virus.

Authors:  Y Wang; P Chen; X Wu; A L Sun; H Wang; Y A Zhu; Z P Li
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

4.  Hierarchic and cooperative binding of the rat liver nuclear protein C/EBP at the hepatitis B virus enhancer.

Authors:  R Dikstein; O Faktor; Y Shaul
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

5.  Promoters for synthesis of the pre-C and pregenomic mRNAs of human hepatitis B virus are genetically distinct and differentially regulated.

Authors:  X Yu; J E Mertz
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

6.  The transcriptional activation and repression domains of RFX1, a context-dependent regulator, can mutually neutralize their activities.

Authors:  Y Katan; R Agami; Y Shaul
Journal:  Nucleic Acids Res       Date:  1997-09-15       Impact factor: 16.971

7.  A single element within the hepatitis B virus enhancer binds multiple proteins and responds to multiple stimuli.

Authors:  O Faktor; S Budlovsky; R Ben-Levy; Y Shaul
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

8.  Functional organization of the hepatitis B virus enhancer.

Authors:  R Dikstein; O Faktor; R Ben-Levy; Y Shaul
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

9.  White spot syndrome virus annexes a shrimp STAT to enhance expression of the immediate-early gene ie1.

Authors:  Wang-Jing Liu; Yun-Shiang Chang; Andrew H-J Wang; Guang-Hsiung Kou; Chu-Fang Lo
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

10.  Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: trans-activation and repression by CCAAT/enhancer binding protein.

Authors:  M López-Cabrera; J Letovsky; K Q Hu; A Siddiqui
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.